Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
The ASSURE study: HIV-1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + atazanavir. [electronic resource] by
- Wohl, D A
- Bhatti, L
- Small, C B
- Edelstein, H
- Zhao, H H
- Margolis, D A
- DeJesus, E
- Weinberg, W G
- Ross, L L
- Shaefer, M S
Producer: 20161213
In:
HIV medicine vol. 17
Availability: No items available.
|
|
|
9.
|
Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers. [electronic resource] by
- Jacobson, J M
- Greenspan, J S
- Spritzler, J
- Fox, L
- Fahey, J L
- Jackson, J B
- Chernoff, M
- Wohl, D A
- Pulvirenti, J J
- Hooton, T M
- Shikuma, C
Producer: 20010222
In:
The Journal of infectious diseases vol. 183
Availability: No items available.
|
|
|
10.
|
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. [electronic resource] by
- Jacobson, J M
- Greenspan, J S
- Spritzler, J
- Ketter, N
- Fahey, J L
- Jackson, J B
- Fox, L
- Chernoff, M
- Wu, A W
- MacPhail, L A
- Vasquez, G J
- Wohl, D A
Producer: 19970522
In:
The New England journal of medicine vol. 336
Availability: No items available.
|
|
|
11.
|
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030. [electronic resource] by
- Wohl, D A
- Kendall, M A
- Andersen, J
- Crumpacker, C
- Spector, S A
- Feinberg, J
- Alston-Smith, B
- Owens, S
- Chafey, S
- Marco, M
- Maxwell, S
- Lurain, N
- Jabs, D
- Benson, C
- Keiser, P
- Jacobson, M A
Producer: 20091015
In:
HIV clinical trials vol. 10
Availability: No items available.
|
|
|
12.
|
STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use. [electronic resource] by
- Khan, M R
- Golin, C E
- Friedman, S R
- Scheidell, J D
- Adimora, A A
- Judon-Monk, S
- Hobbs, M M
- Dockery, G
- Griffin, S
- Oza, K K
- Myers, D
- Hu, H
- Medina, K P
- Wohl, D A
Producer: 20160215
In:
AIDS and behavior vol. 19
Availability: No items available.
|
|
|
13.
|
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. [electronic resource] by
- Jacobson, J M
- Spritzler, J
- Fox, L
- Fahey, J L
- Jackson, J B
- Chernoff, M
- Wohl, D A
- Wu, A W
- Hooton, T M
- Sha, B E
- Shikuma, C M
- MacPhail, L A
- Simpson, D M
- Trapnell, C B
- Basgoz, N
Producer: 19990729
In:
The Journal of infectious diseases vol. 180
Availability: No items available.
|
|
|
14.
|
The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. [electronic resource] by
- Wohl, D A
- Kendall, M A
- Owens, S
- Holland, G
- Nokta, M
- Spector, S A
- Schrier, R
- Fiscus, S
- Davis, M
- Jacobson, M A
- Currier, J S
- Squires, K
- Alston-Smith, B
- Andersen, J
- Freeman, W R
- Higgins, M
- Torriani, F J
Producer: 20051110
In:
HIV clinical trials vol. 6
Availability: No items available.
|
|
|
15.
|
Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy. [electronic resource] by
- Wohl, D A
- McComsey, G
- Tebas, P
- Brown, T T
- Glesby, M J
- Reeds, D
- Shikuma, C
- Mulligan, K
- Dube, M
- Wininger, D
- Huang, J
- Revuelta, M
- Currier, J
- Swindells, S
- Fichtenbaum, C
- Basar, M
- Tungsiripat, M
- Meyer, W
- Weihe, J
- Wanke, C
Producer: 20061016
In:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 43
Availability: No items available.
|